Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Gold-plated Nanocrystals Could Help Fight Multiple Sclerosis
Disease Discoveries

Gold-plated Nanocrystals Could Help Fight Multiple Sclerosis

By Will DossMar 13, 2020
Share
Facebook Twitter Email
Stephen Miller, PhD, the Judy Gugenheim Research Professor of Microbiology-Immunology was senior author of the study published in Scientific Reports.

Gold-plated nanoparticles could rebuild nerves damaged by multiple sclerosis, according to a Northwestern Medicine study recently published in Scientific Reports.

There is no current therapy for multiple sclerosis (MS) that helps repair nerve cells, so these findings point to a possible breakthrough, according to Stephen Miller, PhD, the Judy Gugenheim Research Professor of Microbiology-Immunology and senior author of the study.

“At first, I was a little skeptical that gold nanocrystals could repair myelin, but it actually worked,” said Miller, who is also a professor of Dermatology and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

MS is an autoimmune disease in which immune cells mistakenly attack myelin, a fatty sheath that surrounds and insulates nerve endings. When myelin or the nerves themselves are damaged in MS, nerve cell communications slows or stops, causing a variety of neurological symptoms.

Current FDA-approved therapies for MS are limited to immunosuppressive drugs, aimed at dampening the harmful immune system activity. However, these drugs are global immune system inhibitors, leading to significant side effects for patients, Miller said.

“People become more susceptible to opportunistic infections and have higher rates of cancer if you’re on these drugs long-term,” Miller said.

Miller’s laboratory has been investigating more specific drugs that only target the culprit immune cells, but even with promising targets, these drugs are only half of the equation. Patients with MS usually aren’t diagnosed until the disease has significantly progressed and they start to show symptoms – by the time treatment begins, substantial nerve damage has already occurred.

“If we can combine the antigen-specific immune therapy with a myelin repair drug, we could actually see recovery,” Miller said.

There are a variety of potential myelin repair drugs currently being investigated, but one interesting approach is gold-plated nanocrystals. Preliminary studies showed these nanoparticles help jump-start myelin production by stimulating oligodendrocytes — the cells that create and lay down myelin onto nerve fibers.

In the current study, Miller examined the effects of gold nanocrystals in mouse models of MS. The investigators administered the nanocrystals orally, and found they did indeed stimulate re-myelination of nerve endings. Further analysis revealed that these nanocrystals were absorbed by oligodendrocytes — boosting these cells’ metabolism — which likely allowed oligodendrocytes to create and deposit myelin at a higher rate.

“These nanocrystals actually ‘rev up’ oligodendrocytes, and they appear to produce more myelin,” Miller said.

The specifics of how these nanocrystals increase oligodendrocyte metabolism are still unknown, but this is promising subject for future study, as any effective therapy for MS will require a dual approach, according to Miller.

“I don’t think a myelin repair drug would work on its own,” Miller said. “It has to be combined with immunotherapeutic drugs.”

This study was funded by Clene Nanomedicine, which manufactures nanocrystals.

Dermatology Microbiology Research
Share. Facebook Twitter Email

Related Posts

Humans are Not Just Big Mice: Identifying Science’s Muscle-Scaling Problem

Mar 20, 2023

Predicting Risk of Blood Clots in Brain Tumors

Mar 16, 2023

Understanding How Exercise Induces Systemic Metabolic Benefits

Mar 15, 2023

Comments are closed.

Latest News

Humans are Not Just Big Mice: Identifying Science’s Muscle-Scaling Problem

Mar 20, 2023

AOA Honors New Members

Mar 20, 2023

Celebrating Feinberg’s 2023 Match Day

Mar 17, 2023

Predicting Risk of Blood Clots in Brain Tumors

Mar 16, 2023

Understanding How Exercise Induces Systemic Metabolic Benefits

Mar 15, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
_5NM1245
230204_SERIO_MANDELL_Feinberg_Formal_0928
_5NM1715
_5NM0526
_5NM1026 (1)
_5NM1906
_5NM2173
230204_SERIO_MANDELL_Feinberg_Formal_0896
230204_SERIO_MANDELL_Feinberg_Formal_1113
230204_SERIO_MANDELL_Feinberg_Formal_1868
230204_SERIO_MANDELL_Feinberg_Formal_1237
230204_SERIO_MANDELL_Feinberg_Formal_1172

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.